As of November 2024 Revive Therapeutics has 339.37M shares outstanding, a increase of 6.13% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 339.37M | 6.13% |
2022 | 319.76M | 19.54% |
2021 | 267.49M | 150.28% |
2020 | 106.88M | - |